AUTHOR=Annandale M. , Daniels L. J. , Li X. , Neale J. P. H. , Chau A. H. L. , Ambalawanar H. A. , James S. L. , Koutsifeli P. , Delbridge L. M. D. , Mellor K. M. TITLE=Fructose Metabolism and Cardiac Metabolic Stress JOURNAL=Frontiers in Pharmacology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.695486 DOI=10.3389/fphar.2021.695486 ISSN=1663-9812 ABSTRACT=
Cardiovascular disease is one of the leading causes of mortality in diabetes. High fructose consumption has been linked with the development of diabetes and cardiovascular disease. Serum and cardiac tissue fructose levels are elevated in diabetic patients, and cardiac production of fructose via the intracellular polyol pathway is upregulated. The question of whether direct myocardial fructose exposure and upregulated fructose metabolism have potential to induce cardiac fructose toxicity in metabolic stress settings arises. Unlike tightly-regulated glucose metabolism, fructose bypasses the rate-limiting glycolytic enzyme, phosphofructokinase, and proceeds through glycolysis in an unregulated manner.